Clinical trial

Inflammation and Co-Infections in D²EFT

NCT04183738

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2021-02-01

PhasePHASE4

Study timeline

Study start (estimated)2021-02-01Date precision: day

Registry last updated2020-11-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-infection/Aidsunresolved

Human Herpesvirus 4 Infectionsunresolved

Cytomegalovirus Infectionsunresolved

Human Herpesvirus 8 Infectionunresolved

Human Papilloma Virusunresolved

Interventions

DolutegravirDRUG

Sponsors & collaborators

Kirby Institutelead sponsor

Frederick National Laboratory for Cancer Researchcollaborator

UNITAIDcollaborator

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

ViiV Healthcarecollaborator

Janssen Pharmaceuticacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04183738 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.